6TH ANNUAL JAPANESE REGENERATIVE MEDICINE SYMPOSIUM
PLENARY Session : Wednesday, January 24, 2018
Japan has a fully integrated plan to advance and accelerate regenerative medicine products. Key Japanese leaders from academia, industry and government will present at this must-attend for anyone seeking to gain first-hand knowledge and insight into what is happening in Japan.
Chair’s Introduction: Takashi Asada, PhD, Professor, Kyoto University
Symposium Overview: Norio Nakatsuji, Professor Emeritus, Kyoto University and Chief Advisor, Stem Cell & Device Lab., Inc.
Keynote Address from Academia: Hideyuki Okano, MD, PhD Professor, Keio University Medical School; Director of the Japanese Society for Regenerative Medicine (JSRM)
Regulator’s Perspective: Yoji Sato, PhD, Head, Division of Cell-Based Therapeutic Products, National Institute of Health Sciences (Japan)
Industry Keynote Address: Akihiko Iwai, PhD Vice President, Astellas Pharma, Inc.; Vice Chairman, Forum for Innovative Regenerative Medicine (FIRM)
Masato Ibuki, Regenerative Medicine and Cell Therapy Laboratories, KANEKA Corporation
Masayo Yumoto, PhD, Group Leader, Basic Research Group, Regenerative Medicine Research & Planning Division, Rohto Pharmaceutical, Co., Ltd
Regenerative Medicine CMOs in Japan
A recent conversation with long-time Phacilitate collaborators and Japanese sector experts, CJ Partners, highlighted the quite extraordinary recent growth in the Japanese specialist CMO market – but nowhere else could we find a definitive list of the players in this rapidly evolving sector and their capabilities. With manufacturing such a critical and complex component for any cell & gene therapy company seeking to develop and commercialise in Japan, we felt it was high time someone put together a definitive, up-to-the-minute list of the specialist CMO options available across the nation to serve as a reference point for the global sector.
We hope you enjoy this unique infographic!